COCHW
HealthcareEnvoy Medical Inc - Warrants (29/09/2028)
$0.06-0.01 (-13.79%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving COCHW Today?
No stock-specific AI insight has been generated for COCHW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.03$0.09
$0.06
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding—
COCHW News
20 articles- Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear ImplantYahoo Finance·Apr 28, 2026
- Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear ImplantYahoo Finance·Apr 22, 2026
- Envoy Medical Appoints Chas McKhann to Board of DirectorsYahoo Finance·Apr 16, 2026
- Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear ImplantYahoo Finance·Apr 1, 2026
- Envoy Medical Reports Full Year 2025 Financial ResultsYahoo Finance·Mar 23, 2026
- Envoy Medical Regains Compliance with Nasdaq Listing RequirementYahoo Finance·Feb 24, 2026
- Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing SpaceYahoo Finance·Feb 23, 2026
- Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical TrialYahoo Finance·Feb 19, 2026
- Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance·Nov 10, 2025
- Envoy Medical Reports Third Quarter 2025 Financial and Operational ResultsYahoo Finance·Nov 10, 2025
- Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?Yahoo Finance·Nov 6, 2025
- Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical TrialYahoo Finance·Nov 4, 2025
- Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear ImplantYahoo Finance·Oct 29, 2025
- Envoy Medical Receives Positive Listing Determination from NASDAQYahoo Finance·Oct 27, 2025
- Envoy Medical to Present at the Virtual Technology Investor Conference on October 28thYahoo Finance·Oct 23, 2025
- Bears are Losing Control Over Envoy Medical, Inc. (COCH), Here's Why It's a 'Buy' NowYahoo Finance·Oct 20, 2025
- Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesYahoo Finance·Oct 9, 2025
- Top Midday DeclinersYahoo Finance·Oct 8, 2025
- Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesYahoo Finance·Oct 8, 2025
- Sector Update: Health Care Stocks Edge Down Late AfternoonYahoo Finance·Oct 7, 2025
All 20 articles loaded
Price Data
Open$0.00
Previous Close$0.06
Day High$0.00
Day Low$0.00
52 Week High$0.09
52 Week Low$0.03
52-Week Range
$0.03$0.09
$0.06
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding—
About Envoy Medical Inc - Warrants (29/09/2028)
Envoy Medical Corporation manufactures and markets an implantable hearing aid device. The company is headquartered in White Bear Lake, Minnesota.
HealthcareORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—